iCAD ICAD Stock
iCAD Price Chart
iCAD ICAD Financial and Trading Overview
iCAD stock price | 1.98 USD |
Previous Close | 1.17 USD |
Open | 1.17 USD |
Bid | 0 USD x 2200 |
Ask | 0 USD x 3200 |
Day's Range | 1.16 - 1.2 USD |
52 Week Range | 1.05 - 4.59 USD |
Volume | 158.69K USD |
Avg. Volume | 174.22K USD |
Market Cap | 30.54M USD |
Beta (5Y Monthly) | 1.132746 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.21 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.25 USD |
ICAD Valuation Measures
Enterprise Value | 13.1M USD |
Trailing P/E | N/A |
Forward P/E | -3.2432432 |
PEG Ratio (5 yr expected) | -0.17 |
Price/Sales (ttm) | 1.1655285 |
Price/Book (mrq) | 0.9561753 |
Enterprise Value/Revenue | 0.5 |
Enterprise Value/EBITDA | -0.947 |
Trading Information
iCAD Stock Price History
Beta (5Y Monthly) | 1.132746 |
52-Week Change | -68.91% |
S&P500 52-Week Change | 20.43% |
52 Week High | 4.59 USD |
52 Week Low | 1.05 USD |
50-Day Moving Average | 1.34 USD |
200-Day Moving Average | 1.87 USD |
ICAD Share Statistics
Avg. Volume (3 month) | 174.22K USD |
Avg. Daily Volume (10-Days) | 219.54K USD |
Shares Outstanding | 25.45M |
Float | 23.52M |
Short Ratio | 1.63 |
% Held by Insiders | 7.31% |
% Held by Institutions | 45.58% |
Shares Short | 246.1K |
Short % of Float | 1.16% |
Short % of Shares Outstanding | 0.96% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -53.012% |
Operating Margin (ttm) | -54.70% |
Gross Margin | 72.22% |
EBITDA Margin | -52.77% |
Management Effectiveness
Return on Assets (ttm) | -16.84% |
Return on Equity (ttm) | -36.81% |
Income Statement
Revenue (ttm) | 26.2M USD |
Revenue Per Share (ttm) | 1.04 USD |
Quarterly Revenue Growth (yoy) | -23.20% |
Gross Profit (ttm) | 20.11M USD |
EBITDA | -13827000 USD |
Net Income Avi to Common (ttm) | -13889000 USD |
Diluted EPS (ttm) | -0.54 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 19.66M USD |
Total Cash Per Share (mrq) | 0.78 USD |
Total Debt (mrq) | 3.21M USD |
Total Debt/Equity (mrq) | 10.12 USD |
Current Ratio (mrq) | 2.655 |
Book Value Per Share (mrq) | 1.255 |
Cash Flow Statement
Operating Cash Flow (ttm) | -9869000 USD |
Levered Free Cash Flow (ttm) | -4996750 USD |
Profile of iCAD
Country | United States |
State | NH |
City | Nashua |
Address | 98 Spit Brook Road |
ZIP | 03062 |
Phone | 603 882 5200 |
Website | https://www.icadmed.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 108 |
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company's breast AI suite includes cancer detection, automated density assessment, and breast cancer risk assessment solutions for both 2D and 3D mammography. It offers PowerLook, a back-end architecture platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and PowerLook Density Assessment provides automated, consistent, and standardized breast density assessments. The company also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a clinical decision support tool that provides breast cancer risk estimation based on a screening mammogram; and VeraLook, a solution designed to support detection of colonic polyps in conjunction with Computed Tomography Colonography. In addition, it offers Xoft Axxent electronic brachytherapy systems for the treatment of early-stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.
Q&A For iCAD Stock
What is a current ICAD stock price?
iCAD ICAD stock price today per share is 1.98 USD.
How to purchase iCAD stock?
You can buy ICAD shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for iCAD?
The stock symbol or ticker of iCAD is ICAD.
Which industry does the iCAD company belong to?
The iCAD industry is Medical Devices.
How many shares does iCAD have in circulation?
The max supply of iCAD shares is 26.35M.
What is iCAD Price to Earnings Ratio (PE Ratio)?
iCAD PE Ratio is now.
What was iCAD earnings per share over the trailing 12 months (TTM)?
iCAD EPS is -0.21 USD over the trailing 12 months.
Which sector does the iCAD company belong to?
The iCAD sector is Healthcare.
iCAD ICAD included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 17449.89 USD — |
+0.87
|
6.97B USD — | 17149.36 USD — | 17506.58 USD — | — - | 6.97B USD — |
NASDAQ Composite Total Return I XCMP | 21356.17 USD — |
+0.87
|
— — | 20988.36 USD — | 21425.55 USD — | — - | — — |
NASDAQ Eurozone Real Estate Lg NQEURO8600LMT | 1319.46 USD — |
<0.01
|
— — | 1305.84 USD — | 1341.19 USD — | — - | — — |
NASDAQ HealthCare IXHC | 929.13 USD — |
-1.85
|
— — | 925.14 USD — | 947.12 USD — | — - | — — |
NASDAQ Capital Market Composite RCMP | 99.81 USD — |
-1.04
|
— — | 99.07 USD — | 101.21 USD — | — - | — — |
- {{ link.label }} {{link}}